TrialAmerican journal of respiratory and critical care medicine2019

Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.

Michael I Polkey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.